2023 annual financial data
Cocrystal Pharma 2023 Operating margin
Cocrystal Pharma 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -18,559,000 USD and net income was -17,984,000 USD.
Operating cash flow was -14,666,000 USD.
Get free Cocrystal Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,559,000 USD
- Net income
- -17,984,000 USD
- Operating cash flow
- -14,666,000 USD